Hernan Bazan, MD, specializes in vascular surgery at Ochsner Health. Dr. Hernan Bazan completed his undergraduate work at Vanderbilt University (BS, 1994) and his medical school training at Georgetown University (MD, 2000) in Washington, D.C. During his medical school training, he was a Howard Hughes Medical Institutes Research Scholar at the National Institutes of Health (HHMI-NIH Research Scholars Program) in Bethesda, Maryland (1996 - 1998). He conducted his general surgery training at The Mount Sinai Hospital in New York (2000 - 2005) and his vascular surgery fellowship at Yale University / Yale-New Haven Hospital (2005 - 2007) in New Haven, Connecticut. Dr. Bazan is a full-time physician board-certified in vascular surgery and has been at Ochsner since 2010. He is also the program director for the Vascular Surgery Fellowship at Ochsner. During his training, he was elected member of the medical honor society Alpha Omega Alpha (AOA), The Arnold P. Gold Foundation, and numerous vascular surgery societies. He was awarded the NIH-HHMI Continuing Medical Studies Award for the work he conducted during his time at the NIH. During his surgical residency at The Mount Sinai Hospital, Dr. Bazan was awarded the Arthur H. Aufses, Sr. Prize in Surgery by the faculty for scholarship, integrity, concern for patients and outstanding ability as a teacher. And, separately, the Arthur H. Aufses, Jr. Prize by fellow junior surgical residents for demonstrating overall excellence in surgical mentorship. He has also received multiple teaching awards by medical students and fellow surgical residents at Mt. Sinai Hospital and the Ochsner Clinic. Dr. Bazans areas of clinical interests are treatment of carotid artery disease/blockages with awake/cervical block and general anesthesia, carotid stenting, minimally invasive and open approaches to abdominal and thoracic aortic aneurysms and the minimally invasive treatment of leg blockages, particularly in patients with critical limb ischemia. He is the author of over 60 peer-reviewed publications and book chapters. He regularly lectures at national and international societies and forums on cardiovascular disease and carotid disease and stroke. He has an active atherosclerosis translational research program on the mechanisms involved in carotid plaque rupture and stroke. He is the co-inventor of seven patents and is the co-founder of a life sciences company aimed treating chronic pain thru safer novel non-narcotic molecules and a biotechnology company developing unique neuroprotection strategies for acute stroke. He is the PI or Co-I on two NIH/NINDS STTR (small business commercialization) grants to develop a novel non-narcotic and non-toxic analgesic to safely treat acute, chronic and neuropathic pain. He is the co-inventor of seven issued or pending patents and has authored over 50 publications. He and his team have completed Phase 1 clinical trials, paving the way for Phase 2 RCTs in acute and neuropathic pain. He was bestowed the 2024 NIH HEAL Directors Trailblazer Award for this work. Learn more about Dr. Bazan's translational cardiovascular research program or request trial information here: https://research.ochsner.org/translational/programs/laboratory-of-molecular-vascular-disease